NCT06211335
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06211335
Title Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Shyam S.D. Rao
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA